Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.
2.

Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.

Mazzaro C, Zorat F, Comar C, Nascimben F, Bianchini D, Baracetti S, Donada C, Donadon V, Pozzato G.

J Rheumatol. 2003 Aug;30(8):1775-81.

PMID:
12913934
3.

Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon.

Mazzaro C, Colle R, Baracetti S, Nascimben F, Zorat F, Pozzato G.

Clin Exp Rheumatol. 2002 Jan-Feb;20(1):27-34.

PMID:
11892704
4.

Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry.

Pozzato G, Zorat F, Nascimben F, Gregorutti M, Comar C, Baracetti S, Vatta S, Bevilacqua E, Belgrano A, Crovella S, Amoroso A.

Eur J Hum Genet. 2001 Jun;9(6):445-51.

5.

Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis.

Mazzaro C, Panarello G, Carniello S, Faelli A, Mazzi G, Crovatto M, Baracetti S, Nascimben F, Zorat F, Pozzato G, Faccini L, Campanacci L.

Dig Liver Dis. 2000 Nov;32(8):708-15.

PMID:
11142582
6.

Hepatitis C virus risk: a hepatitis C virus related syndrome.

Mazzaro C, Panarello G, Tesio F, Santini G, Crovatto M, Mazzi G, Zorat F, Tulissi P, Pussini E, Baracetti S, Campanacci L, Pozzato G.

J Intern Med. 2000 May;247(5):535-45.

7.

Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus.

Crovatto M, Pozzato G, Zorat F, Pussini E, Nascimben F, Baracetti S, Grando MG, Mazzaro C, Reitano M, Modolo ML, Martelli P, Spada A, Santini G.

Haematologica. 2000 Apr;85(4):356-61.

8.

Recovery from hepatitis C virus-positive cryoglobulinaemic glomerulonephritis after interferon therapy.

Mazzaro C, Faelli A, Baracetti S, Mezzoran L, Pussini E, Zorat F, Pozzato G.

Ital J Gastroenterol Hepatol. 1999 Oct;31(7):601-3.

PMID:
10604101
9.

GBV-C/HGV and HCV infection in mixed cryoglobulinaemia.

Crovatto M, Mazzaro C, Mishiro S, Santini G, Baracetti S, Zorat F, Pozzato G.

Br J Haematol. 1999 Aug;106(2):510-4.

PMID:
10460613
10.

Ethnic difference in the prevalence of monoclonal B-cell proliferation in patients affected by hepatitis C virus chronic liver disease.

Pozzato G, Burrone O, Baba K, Matsumoto M, Hijiiata M, Ota Y, Mazzoran L, Baracetti S, Zorat F, Mishiro S, Efremov DG.

J Hepatol. 1999 Jun;30(6):990-4.

PMID:
10406175
11.

Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection.

Mazzaro C, Pozzato G, Zorat F, Panarello G, Silvestri F, Barillari G, Mazzoran L, Baracetti S, Crovatto M, Santini GF, Donadon V, Faccini L, Campanacci L.

Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):45-53.

PMID:
10091102
12.

Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease.

Mazzoran L, Tamaro G, Mangiarotti MA, Marchi P, Baracetti S, Gerini U, Fanni-Cannelles M, Zorat F, Pozzato G.

Eur J Gastroenterol Hepatol. 1998 Feb;10(2):125-31.

PMID:
9581987
13.

Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.

Mazzoran L, Grassi G, Giacca M, Gerini U, Baracetti S, Fanni-Canelles M, Zorat F, Pozzato G.

Ital J Gastroenterol Hepatol. 1997 Aug;29(4):338-42.

PMID:
9476188

Supplemental Content

Loading ...
Support Center